Andrea Wainer Speaking Fee: Contact Us for Pricing

Andrea Wainer is a seasoned leader in the healthcare industry, serving as the Executive Vice President of Rapid and Molecular Diagnostics at Abbott. Her career trajectory is marked by a commitment to innovation and excellence in medical diagnostics. Andrea has been instrumental in leading teams that develop cutting-edge diagnostic tools, helping to shape the future of medical testing and patient care. Her journey at Abbott began over two decades ago, where she quickly established herself as a key player within the company. Before rising to her current role, Andrea gained extensive experience across various divisions, enhancing her strategic acumen and deepening her understanding of the industry. Prior to focusing on rapid and molecular diagnostics, Andrea contributed to numerous projects that improved the accessibility and accuracy of diagnostic testing. A graduate of a distinguished university, Andrea holds a firm grounding in scientific disciplines. Her academic background laid the foundation for her career in healthcare, nurturing her passion for improving lives through science and technology. Throughout her career, Andrea has been recognized for her exceptional leadership and her ability to foster innovation within large, complex organizations. Andrea's impact extends beyond her immediate role at Abbott. She is an advocate for the healthcare industry, frequently sharing insights on the importance of diagnostics in advancing global health outcomes. Her work has been pivotal in the response to public health challenges, including the development of diagnostic tools during the COVID-19 pandemic. Known for her forward-thinking approach and dedication to mentoring others, Andrea is not only a leader but a source of inspiration for those in the healthcare field. Her professional philosophy underscores collaboration, continual learning, and an unwavering focus on the needs of patients worldwide. Andrea Wainer continues to drive transformative change in healthcare diagnostics, leaving a lasting imprint on the industry and the numerous lives it touches.